Patel Sushil 4
4 · Revolution Medicines, Inc. · Filed Jul 10, 2024
Insider Transaction Report
Form 4
Patel Sushil
Director
Transactions
- Sale
Common Stock
2024-07-09$44.00/sh−2,155$94,820→ 19,948 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-07-09−2,155→ 32,490 totalExercise: $16.80Exp: 2032-06-15→ Common Stock (2,155 underlying) - Exercise/Conversion
Common Stock
2024-07-09$16.80/sh+2,155$36,204→ 22,103 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
- [F2]Includes 8,623 restricted stock units.
- [F3]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.